[HTML][HTML] Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies

K Dhama, F Nainu, A Frediansyah, MI Yatoo… - Journal of infection and …, 2023 - Elsevier
Newly emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
are continuously posing high global public health concerns and panic resulting in waves of …

[HTML][HTML] SARS-CoV-2 variants, vaccines, and host immunity

P Mistry, F Barmania, J Mellet, K Peta… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new beta coronavirus
that emerged at the end of 2019 in the Hubei province of China. SARS-CoV-2 causes …

[HTML][HTML] Detection of a SARS-CoV-2 variant of concern in South Africa

H Tegally, E Wilkinson, M Giovanetti, A Iranzadeh… - Nature, 2021 - nature.com
Continued uncontrolled transmission of SARS-CoV-2 in many parts of the world is creating
conditions for substantial evolutionary changes to the virus,. Here we describe a newly …

[HTML][HTML] Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells

KW Cohen, SL Linderman, Z Moodie, J Czartoski… - Cell Reports …, 2021 - cell.com
Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we
evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based …

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose

CJ Reynolds, C Pade, JM Gibbons, DK Butler, AD Otter… - Science, 2021 - science.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine rollout has
coincided with the spread of variants of concern. We investigated whether single-dose …

[HTML][HTML] Accelerated COVID-19 vaccine development: milestones, lessons, and prospects

K Bok, S Sitar, BS Graham, JR Mascola - Immunity, 2021 - cell.com
The development of effective vaccines to combat infectious diseases is a complex multi-year
and multi-stakeholder process. To accelerate the development of vaccines for coronavirus …

[HTML][HTML] On the origin and evolution of SARS-CoV-2

D Singh, SV Yi - Experimental & molecular medicine, 2021 - nature.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the
ongoing global outbreak of a coronavirus disease (herein referred to as COVID-19). Other …

[HTML][HTML] Efficacy and safety of COVID-19 vaccines: a systematic review and meta-analysis of randomized clinical trials

A Pormohammad, M Zarei, S Ghorbani, M Mohammadi… - Vaccines, 2021 - mdpi.com
The current study systematically reviewed, summarized and meta-analyzed the clinical
features of the vaccines in clinical trials to provide a better estimate of their efficacy, side …

[HTML][HTML] Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA. 1, BA. 2, BA. 2.12. 1, BA. 4, and BA. 5

HF Tseng, BK Ackerson, KJ Bruxvoort, LS Sy… - Nature …, 2023 - nature.com
Studies have reported reduced natural SARS-CoV-2 infection-and vaccine-induced
neutralization against omicron BA. 4/BA. 5 compared with earlier omicron subvariants. This …

[HTML][HTML] Wastewater surveillance of pathogens can inform public health responses

MB Diamond, A Keshaviah, AI Bento, O Conroy-Ben… - Nature Medicine, 2022 - nature.com
Wastewater surveillance of pathogens can inform public health responses | Nature
Medicine Skip to main content Thank you for visiting nature.com. You are using a browser …